UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

Pharmacological reports, 2009-01, Vol.61 (1), p.154-171

2009

Volltextzugriff (PDF)

Effective Use of Tower Cranes over Time in the Selected Construction Process

Buildings (Basel), 2022-04, Vol.12 (4), p.436

2022

Volltextzugriff (PDF)

Comprehensive review of cardiovascular toxicity of drugs and related agents

Medicinal research reviews, 2018-07, Vol.38 (4), p.1332-1403

2018

Volltextzugriff (PDF)

Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection

Antioxidants & redox signaling, 2013-03, Vol.18 (8), p.899-929

2013

Volltextzugriff (PDF)

Tinnitus - an initial symptom of synchronous occurence of paraganglioma and renal cell carcinoma in a germline mutation of the SDHB gene (PGL4 snydrome)

Onkologie (Olomouc), 2023-11, Vol.17 (5), p.316-318

2023

Volltextzugriff (PDF)

Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity

Scientific reports, 2021-02, Vol.11 (1), p.4456-14, Article 4456

2021

Volltextzugriff (PDF)

Structure–Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase IIβ Interactions

Journal of medicinal chemistry, 2021-04, Vol.64 (7), p.3997-4019

2021

Volltextzugriff (PDF)

Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up

PloS one, 2014-05, Vol.9 (5), p.e96055

2014

Volltextzugriff (PDF)

Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation

Circulation. Heart failure, 2021-11, Vol.14 (11), p.e008209

2021

Volltextzugriff (PDF)

Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage

Toxicological sciences, 2024-03, Vol.198 (2), p.288-302

2024

Volltextzugriff (PDF)

Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats

Hypertension research, 2024-09

2024

Volltextzugriff (PDF)

Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo

Clinical science (1979), 2021-08, Vol.135 (15), p.1897-1914

2021

Volltextzugriff (PDF)

Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity

Scientific reports, 2023-06, Vol.13 (1), p.10499-10499, Article 10499

2023

Volltextzugriff (PDF)

Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase II β Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity

The Journal of pharmacology and experimental therapeutics, 2020-06, Vol.373 (3), p.402-415

2020

Volltextzugriff (PDF)

Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up

Clinical science (1979), 2022-01, Vol.136 (1), p.139-161

2022

Volltextzugriff (PDF)

Pharmacokinetics of the Cardioprotective Drug Dexrazoxane and Its Active Metabolite ADR-925 with Focus on Cardiomyocytes and the Heart

The Journal of pharmacology and experimental therapeutics, 2018-03, Vol.364 (3), p.433-446

2018

Volltextzugriff (PDF)

Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells

PloS one, 2013-10, Vol.8 (10), p.e76676

2013

Volltextzugriff (PDF)

Models of Value Creation Measurement in Different Manufacturing Industry Sectors in the Czech Republic

Trendy ekonomiky a managementu, 2018-01, Vol.12 (31), p.101-114

2018

Volltextzugriff (PDF)

Proteomic insights into chronic anthracycline cardiotoxicity

Journal of molecular and cellular cardiology, 2011-05, Vol.50 (5), p.849-862

2011

Volltextzugriff (PDF)

Analysis of construction sub-processes for the evaluation of the real performance of tower cranes

IOP conference series. Materials Science and Engineering, 2021-11, Vol.1203 (2), p.22132

2021

Volltextzugriff (PDF)

Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane

Journal of molecular and cellular cardiology, 2016-02, Vol.91, p.92-103

2016

Volltextzugriff (PDF)

Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways

The Journal of pharmacology and experimental therapeutics, 2012-11, Vol.343 (2), p.468-478

2012

Volltextzugriff (PDF)

Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model

Frontiers in pharmacology, 2024-01, Vol.14, p.1298172-1298172

2024

Volltextzugriff (PDF)

Myofibroblastic tumor of the esophagus - a case report of long-term follow-up and literature review

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2021, Vol.34 (4), p.313

2021

Volltextzugriff (PDF)

Proteomic investigation of embryonic rat heart-derived H9c2 cell line sheds new light on the molecular phenotype of the popular cell model

Experimental cell research, 2015-12, Vol.339 (2), p.174-186

2015

Volltextzugriff (PDF)

1 – 25 von 196

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(165)

Publikationsform

Sprache

Englisch
(195)
Tschechisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

Effective Use of Tower Cranes over Time in the Selected Construction Process

Comprehensive review of cardiovascular toxicity of drugs and related agents

Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection

Tinnitus - an initial symptom of synchronous occurence of paraganglioma and renal cell carcinoma in a germline mutation of the SDHB gene (PGL4 snydrome)

Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase IIβ inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity

Structure–Activity Relationship Study of Dexrazoxane Analogues Reveals ICRF-193 as the Most Potent Bisdioxopiperazine against Anthracycline Toxicity to Cardiomyocytes Due to Its Strong Topoisomerase IIβ Interactions

Molecular remodeling of left and right ventricular myocardium in chronic anthracycline cardiotoxicity and post-treatment follow up

Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation

Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage

Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats

Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo

Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity

Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase II β Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity

Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up

Pharmacokinetics of the Cardioprotective Drug Dexrazoxane and Its Active Metabolite ADR-925 with Focus on Cardiomyocytes and the Heart

Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells

Models of Value Creation Measurement in Different Manufacturing Industry Sectors in the Czech Republic

Proteomic insights into chronic anthracycline cardiotoxicity

Analysis of construction sub-processes for the evaluation of the real performance of tower cranes

Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane

Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways

Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model

Myofibroblastic tumor of the esophagus - a case report of long-term follow-up and literature review

Proteomic investigation of embryonic rat heart-derived H9c2 cell line sheds new light on the molecular phenotype of the popular cell model

Suchergebnisse filtern